Table 2.

Biopharmaceutical drug classification (Kawabata et al., 2011).

BCS class	Solubility	Permeability	% Drug on market	% Drug on pipeline
I	High	High	42	4.5
II	Low	High	30	70
III	High	Low	22	5.5
IV	Low	Low	6	20